CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-18 | SIEGAL JONATHAN Principal Accounting Officer | Option exercise | +420 | 3,985 | ||
| 2026-02-18 | SIEGAL JONATHAN Principal Accounting Officer | Shares withheld for taxes | −188 | $37.41 | $7K | 3,797 |
| 2026-02-18 | SIEGAL JONATHAN Principal Accounting Officer | Option exercise · Restricted Stock Unit | +2,500 | 2,500 | ||
| 2026-02-18 | SIEGAL JONATHAN Principal Accounting Officer | Option exercise · Restricted Stock Unit | +420 | 0 | ||
| 2026-02-18 | Halpin Michael Chief Operating Officer | Option exercise | +5,250 | 21,330 | ||
| 2026-02-18 | Halpin Michael Chief Operating Officer | Shares withheld for taxes | −2,486 | $36.82 | $92K | 18,844 |
| 2026-02-18 | Halpin Michael Chief Operating Officer | Option exercise | +3,825 | 22,669 | ||
| 2026-02-18 | Halpin Michael Chief Operating Officer | Shares withheld for taxes | −1,812 | $37.41 | $68K | 20,857 |
| 2026-02-18 | Halpin Michael Chief Operating Officer | Option exercise · Restricted Stock Unit | +5,250 | 5,250 | ||
| 2026-02-18 | Halpin Michael Chief Operating Officer | Option exercise · Restricted Stock Unit | +3,825 | 0 | ||
| 2026-02-11 | MCLAUGHLIN KEVIN F Director | Option exercise 10b5-1 | +7,000 | $2.63 | $18K | 22,100 |
| 2026-02-11 | MCLAUGHLIN KEVIN F Director | Sale 10b5-1 | −7,000 | $34.66 | $243K | 15,100 |
| 2026-02-11 | MCLAUGHLIN KEVIN F Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | +7,000 | 3,500 | ||
| 2026-01-07 | Halpin Michael Chief Operating Officer | Option exercise 10b5-1 | +10,000 | $16.66 | $167K | 26,080 |
| 2026-01-07 | Halpin Michael Chief Operating Officer | Sale 10b5-1 | −10,000 | $40.48 | $405K | 16,080 |
| 2026-01-07 | Halpin Michael Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | +10,000 | 46,250 | ||
| 2025-12-03 | Wotton Paul K Director | Sale | −2,500 | $37.83 | $95K | 25,602 |
| 2025-12-02 | Hopper Jonathan Mark Chief Medical Officer | Option exercise 10b5-1 | +1,652 | $18.00 | $30K | 68,214 |
| 2025-12-02 | Hopper Jonathan Mark Chief Medical Officer | Sale 10b5-1 | −1,652 | $39.14 | $65K | 66,562 |
| 2025-12-02 | Hopper Jonathan Mark Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | +1,652 | 7,098 |
Page 11 of 75 · 1,497 trades